Journals / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2018 / Cilt: 31 - Sayı: 4

Acute Dystonia Caused by Clomipramine: a Case Report

Klomipraminin neden olduğu akut distoni: Bir olgu sunumu

Pages
396–399
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We wish to draw attention to this rare side effect of clomipramine and tocontribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipraminetreatment in a 19-year-old male patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Drug-induced acute dystonia is a movement disorder that occurs most often with neuroleptics, thoughthere are many drugs in its etiology.
📊
Key Findings & Data:The exact mechanism of antidepressant-associated extrapyramidalside effects (EPS) is not known.
💡
Conclusion & Impact:We wish to draw attention to this rare side effect of clomipramine and tocontribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipraminetreatment in a 19-year-old male patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Drug-induced acute dystonia is a movement disorder that occurs most often with neuroleptics, thoughthere are many drugs in its etiology. The exact mechanism of antidepressant-associated extrapyramidalside effects (EPS) is not known. However, hypotheses including inhibition of dopaminergic function inthe nigrostriatal pathway, impaired balance between dopaminergic, serotonergic, noradrenergic orcholinergic activity, and serotonergic inhibition of dopaminergic functions in the striatum leading toextrapyramidal side effects have been suggested. The number of cases with acute dystonia duringclomipramine use is low. We wish to draw attention to this rare side effect of clomipramine and tocontribute to the literature by presenting a case of acute dystonia on the 5 th day of clomipraminetreatment in a 19-year-old male patient.

Özet

İlaç kullanımıyla ortaya çıkan akut distoni, etiyolojisinde birçok ilacın olduğu ama en sık nöroleptiklerle ortaya çıkan bir hareket bozukluğudur. Antidepresan kullanımı ile ortaya çıkan ekstrapiramidal yan etkilerin oluş mekanizması tam olarak bilinmemektedir. Ancak, dopaminerjik fonksiyonların nigrostriatal yolakta inhibe edilmesi, dopaminerjik, serotonerjik, noradrenerjik veya kolinerjik aktivite arasındaki dengenin bozulması, striatumda dopaminerjik fonksiyonların serotonin tarafından inhibisyonunun ekstrapiramidal yan etkilere yol açması ileri sürülen hipotezlerdendir. Literatürde klomipramin kullanımı sonrasında akut distoni gelişen vaka sayısı nadirdir. Biz 19 yaşındaki erkek hastamızda klomipramin kullanımının 5. gününde ortaya çıkan akut distoni gelişimi olgusunu sunarak klomipraminin nadir görülen bu yan etkisine dikkat çekmek ve literatüre katkıda bulunmak istedik.

🔖

Cite This Article

TABARA, M. F., KORKMAZ, S., BAYKARA, S., ATMACA, M. (2022). Acute Dystonia Caused by Clomipramine: a Case Report. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 31 - Sayı: 4, 396–399. https://ajindex.com/articles/493734

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Ozturk MO. Mental Health and Mental Disorders. Ankara: Nobel Medicine Bookstores, 2015. (Turkish) Domínguez-Morán JA, Callejo JM, Fernández-Ruiz LC, Martínez-Castrillo JC. Acute paroxysmal dystonia induced by fluoxetine. Mov Disord 2001; 16:767-769. [CrossRef] Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997; 17:377-389. [CrossRef] Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants – a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22:148-156. Schillevoort I, van Puijenbroek EP, de Boer A, Roos RA, Jansen PA, Leufkens HG. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case control study using spontaneous reports. Int Clin Psychopharmacol 2002; 17:75-79. [CrossRef] Najjar E, Price LH. Citalopram and dystonia. J Am Acad Child Adolesc Psychiatry 2004; 43:8-9. [CrossRef] Baykara S, Korkmaz S, Taşcı G, Kaya S, Atmaca M. Edema induced with clomipramine. Journal of Mood Disorders (JMOOD) 2016; 6:238-241. [CrossRef] (Turkish) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Fifth ed., Washington DC: American Psychiatric Pub., 2013.
  2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. [CrossRef] Hedenmalm K, Guzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol 2006; 26:192- 197. [CrossRef] Shin HW, Chung SJ. Drug induced parkinsonism. J Clin Neurol 2012; 8:15-21. [CrossRef] Robottom BJ, Shulman LM, Weiner W.J. Drug-induced movement disorders: emergencies and management. Neurol Clin 2012; 30:309-320. [CrossRef] Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug-induced parkinsonism: a review of 17 years’ experience in a regional pharmacovigilance center in France. Mov Disord 2011; 26:2226-2231. [CrossRef] Cunningham Owens DG. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press, 1999. [CrossRef] Pierre JM